Cargando…

Pediatric non alcoholic fatty liver disease: more on novel treatment targets

The mainstay treatment of non alcoholic fatty liver disease (NAFLD) based on weight loss and/or lifestyle changes is most often unsuccessful at all ages, thus requiring the implementation of pharmacological strategies. Targeting insulin resistance and oxidative stress has recently proven unsatisfact...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vajro, Pietro, Paolella, Giulia, Poeta, Marco, Pizza, Cristina, Sangermano, Maria, Massa, Grazia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3723439/ https://www.ncbi.nlm.nih.gov/pubmed/23870449 http://dx.doi.org/10.1186/1471-2431-13-109

Ejemplares similares

Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions
por: Clemente, Maria Grazia, et al.
Publicado: (2016)

Gut–Liver Axis Derangement in Non-Alcoholic Fatty Liver Disease
por: Poeta, Marco, et al.
Publicado: (2017)

Therapeutic options in pediatric non alcoholic fatty liver disease: current status and future directions
por: Vajro, Pietro, et al.
Publicado: (2012)

More on Current Evidences on Probiotics as a Novel Treatment for Non-Alcoholic Fatty Liver Disease
por: Vajro, Pietro, et al.
Publicado: (2013)

Pediatric Fatty Liver and Obesity: Not Always Just a Matter of Non-Alcoholic Fatty Liver Disease
por: Alfani, Renata, et al.
Publicado: (2018)

Fatty liver disease and hypertransaminasemia hiding the association of clinically silent Duchenne muscular dystrophy and hereditary fructose intolerance
por: Paolella, Giulia, et al.
Publicado: (2012)

Editorial: The broader aspects of non-alcoholic fatty liver disease in children
por: Mandato, Claudia, et al.
Publicado: (2022)

Pediatric Acute Liver Failure
por: Mandato, Claudia, et al.
Publicado: (2023)

Oxidative Stress in Non-alcoholic Fatty Liver Disease. An Updated Mini Review
por: Delli Bovi, Anna Pia, et al.
Publicado: (2021)

Challenges in the hepatic histopathology in non-alcoholic fatty liver disease
por: Brunt, Elizabeth M, et al.
Publicado: (2017)

Nutritional problems in children with neuromotor disabilities: an Italian case series
por: Sangermano, Maria, et al.
Publicado: (2014)

Cholestatic jaundice in infancy: struggling with many old and new phenotypes
por: Mandato, Claudia, et al.
Publicado: (2019)

Are the polyol pathway and hyperuricemia partners in the development of non‐alcoholic fatty liver disease in diabetes?
por: Hotta, Nigishi, et al.
Publicado: (2020)

Cancer surveillance in non-alcoholic fatty liver disease: A potential role for lipidomics
por: Best, Jan, et al.
Publicado: (2021)

Pediatric non-alcoholic fatty liver disease: current perspectives on diagnosis and management
por: Di Sessa, Anna, et al.
Publicado: (2019)

Pediatric Non-Alcoholic Fatty Liver Disease
por: Delvin, Edgard, et al.
Publicado: (2015)

Pediatric Non-Alcoholic Fatty Liver Disease
por: Bush, Haley, et al.
Publicado: (2017)

A new noninvasive technique for estimating hepatic triglyceride: will liver biopsy become redundant in diagnosing non-alcoholic fatty liver disease?
por: Betzel, Bark, et al.
Publicado: (2014)

Waist Circumference and Healthy Lifestyle Preferences/Knowledge Monitoring in a Preschool Obesity Prevention Program
por: Poeta, Marco, et al.
Publicado: (2019)

Putting non-alcoholic fatty liver disease on the radar for primary care physicians: how well are we doing?
por: Sanyal, Arun J.
Publicado: (2018)

Assessing the disease burden of non-alcoholic fatty liver disease in the real world – big data and big numbers
por: Schattenberg, Jörn M., et al.
Publicado: (2019)

Platelets in Non-alcoholic Fatty Liver Disease
por: Dalbeni, Andrea, et al.
Publicado: (2022)

Thrombospondin1 as a potential therapeutic target for human nonalcoholic fatty liver disease
por: Song, Yongfeng, et al.
Publicado: (2020)

Health-related quality of life in pediatric liver transplanted patients compared with a chronic liver disease group
por: Gritti, Antonella, et al.
Publicado: (2013)

Gallstone Disease Is Associated with More Severe Liver Damage in Patients with Non-Alcoholic Fatty Liver Disease
por: Fracanzani, Anna Ludovica, et al.
Publicado: (2012)

CRISPR-edited hepatic organoids as drug screening platform for non-alcoholic fatty liver disease
por: Wang, Yinhan, et al.
Publicado: (2023)

Shaping the future of pediatric liver health: unraveling the impact of the new metabolic-associated fatty liver disease definition
por: Ciardullo, Stefano, et al.
Publicado: (2023)

Educ’ Alcool’s misinformation: more mixed messages about alcohol harms
por: Petticrew, Mark P, et al.
Publicado: (2022)

Pediatric Health Mobility: Is it Only an Italian Problem?
por: Paolella, Giulia
Publicado: (2012)

Determinants of hyperglucagonemia in pediatric non-alcoholic fatty liver disease
por: Maruszczak, Katharina, et al.
Publicado: (2022)

Zika Virus Serology: More Diagnostic Targets, more Reliable Answers?
por: Panning, Marcus
Publicado: (2017)

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: guidelines, clinical reality and health economic aspects
por: Toplak, Hermann, et al.
Publicado: (2016)

Three unreported cases of TMEM199-CDG, a rare genetic liver disease with abnormal glycosylation
por: Vajro, Pietro, et al.
Publicado: (2018)

Alcohol Induces More Severe Fatty Liver Disease by Influencing Cholesterol Metabolism
por: Li, Bo, et al.
Publicado: (2019)

Multiple Sclerosis—Related Dietary and Nutritional Issues: An Updated Scoping Review with a Focus on Pediatrics
por: Mandato, Claudia, et al.
Publicado: (2023)

Characterization and burden of Campania children health migration across Italian regions during years 2006–2010: chance and/or necessity?
por: Vajro, Pietro, et al.
Publicado: (2012)

Practice guidance documents for the diagnosis and management of non-alcoholic fatty liver disease—recent updates and open questions
por: Lauschke, Volker M.
Publicado: (2023)

Nutrition and Liver Disease
por: Mandato, Claudia, et al.
Publicado: (2017)

What the New Definition of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Left Behind: Genetically Acquired Fatty Liver Disease (GAFLD)
por: Bril, Fernando
Publicado: (2021)

Alterations of Central Liver Metabolism of Pediatric Patients with Non-Alcoholic Fatty Liver Disease
por: Berndt, Nikolaus, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2og41284ju0krpib3fjfhhcdq1